Symbol: |
CRYGA
|
Description: |
crystallin, gamma A [Source:HGNC Symbol;Acc:2408]
|
Location: |
Chr2:209025464-209028300[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:268
Gene |
Compound |
Gen_sig |
Exp_pattern |
CRYGA |
NSC 103704 |
0.034 |
Down |
CRYGA |
NSC 109834 |
0.039 |
Down |
CRYGA |
NSC 11850 |
0.021 |
Down |
CRYGA |
NSC 11865 |
0.044 |
Down |
CRYGA |
NSC 119911 |
0.031 |
Down |
CRYGA |
NSC 119915 |
0.038 |
Down |
CRYGA |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.047 |
Down |
CRYGA |
VERNOLIDE |
0.011 |
Down |
CRYGA |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.032 |
Down |
CRYGA |
NSC 135371 |
0.038 |
Down |
CRYGA |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.024 |
Down |
CRYGA |
TZT |
0.027 |
Down |
CRYGA |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.04 |
Down |
CRYGA |
NSC 148201 |
0.022 |
Down |
CRYGA |
NSC 166382 |
0.026 |
Down |
Expression pattern: Sensitivity / Resistance
Total:18 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:3
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:5
Gene |
Gen_transcript |
miRNA |
miR_location |
CRYGA |
ENST00000304502 |
hsa-mir-542-5p |
ChrX:133675430-133675452[-] |
CRYGA |
ENST00000304502 |
hsa-mir-638 |
Chr19:10829095-10829119[+] |
CRYGA |
ENST00000304502 |
hsa-mir-643 |
Chr19:52785110-52785131[+] |
CRYGA |
ENST00000304502 |
hsa-mir-891a |
ChrX:145109359-145109380[-] |
CRYGA |
ENST00000304502 |
hsa-mir-891b |
ChrX:145082618-145082639[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|